December 4, 2020         
Burns & Levinson Closes Strategic Growth Investment for GA Foods   •   Scary Mommy And Huggies® Partner To Launch New Series "Up Early Tonight" To Stream On Hulu   •   Gloriae Dei Cantores' Musical Advent Calendar is Available for Listening All the Way to Christmas!   •   Ulta Beauty Announces Third Quarter Fiscal 2020 Results   •   2021 Donate Life Floral Sculpture to Honor Donation and Transplantation Professionals as Donation Healthcare Heroes on New Year&   •   Ellevate Network Rolls Out Second Iteration of Annual Raise Her Voice Campaign In Honor of International Women's Day and Nationa   •   BEERMKR Home Brewing System Is a Beer Lovers Dream Holiday Gift   •   Grant Thornton named one of Working Mother’s Top Companies for Executive Women   •   Nexus Pharmaceuticals Announces Diversity Certification   •   DYSIS Announces Medicare Reimbursement Rates for the New Add-On CPT Code 57465, Which Can Be Used for DYSIS Smart Colposcopy, Ef   •   Byron Allen To Launch TheGrio.TV As An Over-The-Air Broadcast Television Network And Free Digital Streaming App To Target Africa   •   Ministers Qualtrough and Bains explore opportunities to improve accessibility requirements for buildings in Canada   •   Direct Agents Announces Polycultural Offering   •   DDB Latina Celebrates Its Third Time Named As The Most Creative Network At El Ojo de Iberoamerica   •   Global Advisor, Colleen Goggins, Joins ZO® Skin Health's Board Of Directors Following Majority Investment By Blackstone   •   AEO Updates Payment of Deferred First Quarter Cash Dividend of $0.1375 Per Share, Due to Strong Financial Condition   •   BioAesthetics Announces University Clinical Study for its Nipple Reconstruction Graft   •   Greenberg Traurig Mexico City Achieves 100% Score on the Human Rights Campaign Equidad MX LGBTQ+ Survey   •   Communitech’s Fierce Founders Uplift: Levelling the Playing Field and Shattering Glass Ceilings   •   MTV Entertainment Group Launches New Initiative to Fuel the Creation of More BIPOC and Women Owned and Operated Production Compa
Bookmark and Share

Study Yields Breakthrough For Blacks With Heart Disease

 

(SACRAMENTO, Calif.) — UC Davis researchers have discovered that a blood component linked with inflammation can predict coronary artery disease in African-Americans.

Known as lipoprotein-associated phospholipase A2 (Lp-PLA2), the blood factor is also associated with but does not accurately predict heart-disease risk in Caucasians. The findings are published in the current issue of the Journal of Clinical Endocrinology and Metabolism.

“This study suggests that inflammation may be a more important mechanism in heart disease for African-Americans than it is for Caucasians and increases our growing understanding of how heart-disease processes vary in different ethnic groups,” said Lars Berglund, senior study author and associate dean for research at the UC Davis School of Medicine. “The more we appreciate such differences, the better we can individualize treatment and prevention approaches.”

Lp-PLA2 was recently identified as a marker for the inflammatory processes involved in atherosclerosis. It is considered key to the progression and rupture of fatty plaques that can block coronary arteries and lead to heart attacks. It predominately binds to low-density lipoprotein — or LDL — which is a general marker of increased heart-disease risk. Berglund noted, though, that more well-known factors like LDL and high cholesterol cannot provide the whole picture of heart disease.

“There are other important elements of heart disease — like inflammation — that need to be better explained,” he said.

For the current study, Berglund and his team measured Lp-PLA2 levels in the blood of 336 Caucasians and 224 African-Americans who were about to undergo diagnostic coronary arteriography — a test used to determine coronary artery disease in high-risk patients — at two hospitals in New York. Coronary arteriography findings were compared with the amount and activity levels of Lp-PLA2 from each research subject.

During the procedure, contrast dye and X-rays are used to detect narrowed or blocked arteries, indicating the potential for heart attacks.

“Arteriography is highly effective but considered too risky and expensive for general screening,” said Berglund. “That is why researchers are always on the lookout for other reliable predictors of heart-attack risk that can be identified with a simple blood test.”

The outcomes showed that Lp-PLA2 activity was higher among Caucasians and African-Americans with coronary artery disease. In addition, only in African-Americans was the Lp-PLA2 index found to independently predict coronary artery disease.

Although the test for Lp-PLA2 is widely available, Berglund said it is too soon to recommend widespread testing to affect treatment decisions. The study population was not representative of the general population as all participants already had symptoms of heart disease. Berglund’s team plans further studies of Lp-PLA2 and other inflammatory components of the blood in a wider range of patients to get a clearer picture of their roles in predicting heart disease for different ethnic and racial groups. The outcomes of his current study, however, give him hope that African-Americans at high risk for heart disease will one day be treated for inflammation more aggressively and earlier in the disease process.

“This study has helped open the field,” said Berglund. “More information will allow us to better tailor therapy to specific patient needs.”

In addition to Berglund, other study authors included Erdembileg Anuurad and Byambaa Enhkmaa of UC Davis, Thomas Pearson of the University of Rochester and Zeynep Ozturk of the University of Istanbul.

The study was funded by grants from the National Heart, Lung and Blood Institute, the UC Davis Clinical and Translational Science Center and the American Heart Association.

About the Clinical and Translational Science Center:
The UC Davis Clinical and Translational Science Center is part of a national consortium, led by the National Center for Research Resources at the National Institutes of Health, which is improving how biomedical research is conducted across the nation. Its goals are to reduce the time it takes for research discoveries to become treatments for patients, as well as to train the next generation of clinical researchers. For more information, visit www.ucdmc.ucdavis.edu/ctsc.


UC Davis Health System, 2315 Stockton Blvd, Sacramento, CA 95817 United States



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News